Bandhan Mutual Fund has launched a new sectoral scheme — Bandhan Healthcare Fund Direct – Growth, open for subscription from 10th November to 24th November 2025. With a very high-risk profile, this open-ended equity mutual fund aims to generate long-term capital appreciation by investing in healthcare, pharma sector, and allied sectors.
Key NFO Details
| Detail | Information |
| Fund Name | Bandhan Healthcare Fund (Direct – Growth) |
| NFO Period | 10 Nov 2025 to 24 Nov 2025 |
| Allotment Date | 28 Nov 2025 |
| Category | Equity – Sectoral (Pharma & Healthcare) |
| Risk Level | Very High |
| Fund Type | Open-ended |
| Benchmark | BSE Healthcare TRI |
| Minimum Investment | ₹1,000 (lumpsum), ₹500 (SIP) |
| Exit Load | Exit load of 0.50%, if redeemed within 30 days |
| Short-term capital gains (STCG) | Returns are taxed at 20% if you redeem before 1 year |
| Long-term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
Investment Objective
The scheme seeks to:
• Generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies operating in the healthcare sector, pharma, and allied sectors.
This approach focuses on capturing opportunities in India’s expanding healthcare ecosystem — including pharmaceuticals, diagnostics, biotechnology, hospitals, and healthcare services.
How Does This Compare with the Category?
| Time Period | Category Avg. Returns (CAGR) |
| 1 Year | 5.97% |
| 3 Years | 20.71% |
| 5 Years | 18.28% |
| 7 Years | 20.42% |
| 10 Years | 17.39% |
| 15 Years | 16.21% |
| Since Inception | 16.75% |
These figures reflect the strong long-term performance of the healthcare and pharma category, driven by rising healthcare demand and the global expansion of Indian pharma companies.
Should You Invest in This NFO?
You may consider investing in this NFO if:
• You want thematic exposure to India’s fast-growing healthcare and pharma industry.
• You have a high-risk appetite and are seeking long-term growth opportunities.
• You believe in the sector’s potential amid rising healthcare spending and innovation.
However, as a sectoral fund, it is highly concentrated, making it more volatile than diversified equity funds. It’s better suited as a satellite allocation within a broader portfolio.
About Bandhan Mutual Fund
Bandhan Mutual Fund manages ₹1,87,716 Cr AUM (as of September 30, 2025) and offers a variety of high-performing equity schemes across market caps and themes.
| Fund Name | AUM | 1Y | 5Y |
| Bandhan Infrastructure Fund | 1,615 Cr | -4.01% | 33.02% |
| Bandhan Small Cap Fund | 15,738 Cr | 4.66% | 32.30% |
| Bandhan Value Fund | 9,942 Cr | 2.21% | 27.16% |
| Bandhan Large & Mid Cap Fund | 10,818 Cr | 8.86% | 25.91% |
| Bandhan ELSS Tax Saver Fund | 6,948 Cr | 4.49% | 23.40% |
| Bandhan Focused Fund | 1,974 Cr | 6.02% | 18.48% |
Top-performing peers in the healthcare category include:
| Fund Name | Fund Size | 5Y Returns |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | ₹6,227 Cr | 22% p.a. |
| SBI Healthcare Opportunities Fund | ₹3,933 Cr | 21% p.a. |
| DSP Healthcare Fund | ₹3,074 Cr | 19% p.a. |
People Also Read:
- Bajaj Finserv Banking and Financial Services Fund NFO: Riding India’s Financial Growth Wave
- Old Bridge Arbitrage Fund NFO: A Low-Risk Income Option for 2025
- Kotak Rural Opportunities Fund NFO: Tapping into India’s Rural Growth Potential
- LIC MF Consumption Fund NFO: A Play on India’s Consumption Growth
- Axis Income Plus Arbitrage Passive FoF NFO: A Low-Risk Diversified Investment for 2025
Final Thoughts
The Bandhan Healthcare Fund NFO offers investors exposure to one of India’s most promising growth themes — the healthcare and pharma sector.
For those with a long-term horizon and high-risk tolerance, this fund can serve as a thematic addition to a diversified portfolio.
Before investing, review the scheme document carefully to ensure it aligns with your investment goals and risk profile. For a seamless and guided investing experience, consider investing in mutual funds with Torus Digital.
